Cheng-Yi Huang, MD, has published research focused on the long-term outcomes of early use of long-acting injectable antipsychotics in schizophrenia and schizoaffective disorders. Huang's work, appearing in Psychiatrist.com in 2022, explores clinical aspects of treatment strategies for these conditions. Frequent collaborators include Su-Chen Fang and Yu-Hsuan Joni Shao.
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
